104 related articles for article (PubMed ID: 11702675)
1. [Effect of sequential application of calcitonin and parathyroid hormone on bone remodeling process, an experimental research].
Zhang F; Dang G
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(14):836-40. PubMed ID: 11702675
[TBL] [Abstract][Full Text] [Related]
2. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
Li M; Jiao J; Meng XW; Xing XP; Xia WB; Zhou XY; Liu HC; Jiang Y; Wang O; Hu YY; Zhan ZW
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):335-8. PubMed ID: 15854512
[TBL] [Abstract][Full Text] [Related]
3. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
Washimi Y; Ito M; Morishima Y; Taguma K; Ojima Y; Uzawa T; Hori M
Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
[TBL] [Abstract][Full Text] [Related]
4. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT
Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin and the bone fluid compartment: effect of calcitonin and/or parathyroid hormone on plasma radiocalcium changes.
Dopplet SH; Talmage RV
Clin Orthop Relat Res; 1976; (118):242-50. PubMed ID: 954281
[TBL] [Abstract][Full Text] [Related]
6. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
[TBL] [Abstract][Full Text] [Related]
7. Osteoblast hydraulic conductivity is regulated by calcitonin and parathyroid hormone.
Hillsley MV; Frangos JA
J Bone Miner Res; 1996 Jan; 11(1):114-24. PubMed ID: 8770704
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of bone mineralization by parathyroid hormone].
Shimizu M; Tamura T
Clin Calcium; 2004 Jun; 14(6):70-5. PubMed ID: 15577058
[TBL] [Abstract][Full Text] [Related]
9. Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats.
Shirota T; Tashiro M; Ohno K; Yamaguchi A
J Oral Maxillofac Surg; 2003 Apr; 61(4):471-80. PubMed ID: 12684966
[TBL] [Abstract][Full Text] [Related]
10. Changes in calcium phosphate on bone surfaces and in lining cells after the administration of parathyroid hormone or calcitonin.
Norimatsu H; Yamamoto T; Ozawa H; Talmage RV
Clin Orthop Relat Res; 1982 Apr; (164):271-8. PubMed ID: 7067299
[TBL] [Abstract][Full Text] [Related]
11. Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension.
Chunxiao W; Jingjing L; Yire X; Min D; Zhaohui W; Gaofu Q; Xiangchun S; Xuejun W; Jie W; Taiming L
Regul Pept; 2007 Jun; 141(1-3):35-43. PubMed ID: 17300845
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone: a double-edged sword for bone metabolism.
Qin L; Raggatt LJ; Partridge NC
Trends Endocrinol Metab; 2004 Mar; 15(2):60-5. PubMed ID: 15036251
[TBL] [Abstract][Full Text] [Related]
13. Effect of calcitonin on bone regeneration in male rats: a histomorphometric analysis.
Almeida JD; Arisawa EA; da Rocha RF; Carvalho YR
Int J Oral Maxillofac Surg; 2007 May; 36(5):435-40. PubMed ID: 17275259
[TBL] [Abstract][Full Text] [Related]
14. Effect of sevelamer hydrochloride on bone in experimental uremic rats.
Kuwahara M; Inoshita S; Terada Y; Sasaki S
Ther Apher Dial; 2009 Feb; 13(1):42-8. PubMed ID: 19379169
[TBL] [Abstract][Full Text] [Related]
15. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
[TBL] [Abstract][Full Text] [Related]
16. [Morphologic study of iliac crest spongiosa in patients with osteoporosis treated with combination therapy of pulsatile administration of parathyroid hormone (1-38 hPTH) and sequential addition of calcitonin nasal spray].
Vogel M; Hesch RD; Delling G
Med Klin (Munich); 1990 Feb; 85(2):82-6. PubMed ID: 2319988
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone can reverse glucocorticoid-induced low bone turnover on cortical but not on cancellous bone surfaces in adult Wistar rats.
Ortoft G; Andreassen TT; Oxlund H
Bone; 2005 Jan; 36(1):123-33. PubMed ID: 15664010
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model.
O'Loughlin PF; Cunningham ME; Bukata SV; Tomin E; Poynton AR; Doty SB; Sama AA; Lane JM
Spine (Phila Pa 1976); 2009 Jan; 34(2):121-30. PubMed ID: 19112335
[TBL] [Abstract][Full Text] [Related]
19. Modulatory effects of Aroclors 1221 and 1254 on bone turnover and vertebral histology in intact and ovariectomized rats.
Yilmaz B; Seyran AD; Sandal S; Aydin M; Colakoglu N; Kocer M; Carpenter DO
Toxicol Lett; 2006 Oct; 166(3):276-84. PubMed ID: 16978806
[TBL] [Abstract][Full Text] [Related]
20. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
Wada S; Fukawa T; Kamiya S
Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
